Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Canada clears Uroplasty's next-generation bladder device:

This article was originally published in Clinica

Executive Summary

Canadian regulators have given Uroplasty the all-clear to sell a next-generation version of its Urgent PC neuromodulation system for treating overactive bladder symptoms of urge incontinence, urinary urgency and urinary frequency. The redesigned product comprises enhanced controls, visual and auditory signals of operational status and an ergonomic device shape, the Minnetonka, Minnesota firm said, adding that Canada was the first country to approve the new system. The ergonomic design and enhanced user interface offers clinicians ease of use, while effectively delivering percutaneous tibial nerve stimulation therapy, the company noted.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052047

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel